Roche aims to lead big pharma in 21st century antibiotic discovery challenge
This article was originally published in Scrip
Executive Summary
In the space of four months Roche has signed two deals with small drug discovery companies for the development of new antibiotics; an area that had become very much devoid of big pharma action in recent years.